5% Drop Today In Bristol-Myers Squibb Stock – Mon Jun 4 2018

Bristol-Myers Squibb Stock BMY

For the third time in a year and a half, disappointing clinical trials from Bristol-Myers Squibb has sunk their stock.

Here is an analysis of what is occurring in the stock and the outlook for trades shortly.

 This Bristol-Myers Squibb Stock article is for FullyInformed Members.

Bristol-Myers Squibb Stock – June 4 2018

 Internal Stock and Option Trades Links

Portfolio Listing by Years

My Principal Stocks Index

Trade Ideas for Members

Trade Alerts for Members

Put Selling Strategies

Put Selling Strategies For Members

Covered Calls Strategies

Covered Calls Strategies For Members

Profit And Income Strategies Index

Stock and Option Strategies For Members

Stock And Option Trades Explained For Members

Ask A Question About A Trade You Are In

Sign My Guestbook

Visit My Shop

Join The Free Options Forum